Objective: To determine the perioperative mortality and the share of anaesthesiological activity in it.

Design: Retrospective, descriptive.

Setting: VU University Hospital, Amsterdam.

Method: Patients who in the period 1989-1994 had died within 7 days after a clinical surgical intervention were identified using the database of the hospital information system. The following data concerning these patients were collected from the database of the department of Anaesthesiology: age, sex, classification according to the American Society of Anesthesiologists (ASA), urgency (elective or emergency operation), type of operation (12 categories), duration of the operation, time and place of death. Four independent investigators classified the deceased patients with the aid of their medical files as to the degree of connection between the anaesthesiological activity and the death according to the Edwards classification.

Results: A total of 62,969 operations had been performed. following which 314 patients (0.5%) had died within 7 days. Death was connected with the anaesthesiological activity in 16 cases (2.5 per 10,000 operations): there was a connection with the anaesthesiological activity exclusively in two patients (0.3 per 10,000 operations) and with both anaesthesiological and surgical factors in 14 patients (2.2 per 10,000 operations). Advanced age, male sex, a higher ASA category, traumatological operations and emergency operations were associated with a higher mortality rate.

Conclusion: The mortality rate within 7 days after a clinical surgical intervention was 0.5%. A connection with anaesthesiological activity was present in 2.5 per 10,000 operations.

Download full-text PDF

Source

Publication Analysis

Top Keywords

anaesthesiological activity
20
10000 operations
16
connection anaesthesiological
12
university hospital
8
died days
8
days clinical
8
clinical surgical
8
surgical intervention
8
patients 10000
8
operations
7

Similar Publications

Effects of coagulation factors on bone cells and consequences of their absence in haemophilia a patients.

Sci Rep

October 2024

Center for Hemorrhagic and Thrombotic Diseases, Foundation University Hospital "A. Gemelli", IRCCS, Catholic University of the Sacred Heart, Largo Agostino Gemelli 8, 00168, Rome, Italy.

Haemophilia is associated with reduced bone mass and mineral density. Due to the rarity of the disease and the heterogeneity among the studies, the pathogenesis of bone loss is still under investigation. We studied the effects of coagulation factors on bone cells and characterized in a pilot study the osteoclastogenic potential of patients' osteoclast precursors.

View Article and Find Full Text PDF

Introduction: Due to the increasing number of cases and the levels of mortality, colorectal cancer is still a major health problem. Therefore, the growing interest in the quality of life of patients and the assessment of the quality of life of patients with colorectal cancer seems to be particularly important. The aim of the study was to investigate and determine factors that have a significant impact on the QoL of patients who were diagnosed with colorectal cancer that was surgically treated in the Surgical Department of the 4th Military Clinical Hospital in Wroclaw.

View Article and Find Full Text PDF

Mixed cryoglobulinemia vasculitis (MCV) is caused in ~90% of cases by chronic hepatitis C virus (HCVMCV) and more rarely by hepatitis B virus (HBV) infection, or apparently noninfectious. HCVMCV develops in only ~5% of patients with chronic hepatitis C (CHC), but risk factors other than female gender have not been identified so far. We conducted a retrospective case control study investigating whether past active HBV infection, defined by hepatitis B surface antigen (HBsAg) seroclearance and anti-core antibody (HBcAb) positivity, could be a risk factor for developing HCVMCV.

View Article and Find Full Text PDF

Background: Prolonging effects of adjuncts to local anaesthetics in peripheral nerve blocks have been demonstrated in randomised clinical trials. The chosen primary outcome and anticipated effect size have major impact on the clinical relevance of results in these trials. This scoping review aims to provide an overview of frequently used outcomes and anticipated effect sizes in randomised trials on peripheral nerve block adjuncts.

View Article and Find Full Text PDF

Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study.

J Rheumatol

November 2024

C. Tani, MD, F. Trentin, MD, M. Mosca, MD, Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Objective: To report real-world experience on the use of anifrolumab (ANI) in refractory systemic lupus erythematosus (SLE).

Methods: The present study is a multicenter, retrospective study involving 9 Italian SLE referral centers participating in a compassionate use program for the use of ANI in adult patients with active SLE in whom all the available treatment choices failed, were not tolerated, or were contraindicated. At baseline and 1, 3, 6, 9, and 12 months of treatment, overall and organ-specific disease activity, flares, daily glucocorticoid (GC) dose, and adverse events were recorded.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!